Cargando…
In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
Nanotechnology has tremendous potential to contribute to cancer immunotherapy. The “in situ vaccination” immunotherapy strategy directly manipulates identified tumours to overcome local tumour-mediated immunosuppression and subsequently stimulates systemic anti-tumour immunity to treat metastases. W...
Autores principales: | Lizotte, P. H., Wen, A. M., Sheen, M. R., Fields, J., Rojanasopondist, P., Steinmetz, N. F., Fiering, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777632/ https://www.ncbi.nlm.nih.gov/pubmed/26689376 http://dx.doi.org/10.1038/nnano.2015.292 |
Ejemplares similares
-
In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade
por: Mao, Chenkai, et al.
Publicado: (2022) -
Radiation Therapy Combined with Cowpea Mosaic Virus
Nanoparticle in Situ Vaccination Initiates Immune-Mediated Tumor Regression
por: Patel, Ravi, et al.
Publicado: (2018) -
Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth
por: Stump, Courtney T., et al.
Publicado: (2021) -
Cowpea Mosaic Virus Nanoparticle Enhancement of Hypofractionated Radiation in a B16 Murine Melanoma Model
por: Duval, Kayla E. A., et al.
Publicado: (2020) -
Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer
por: Alonso-Miguel, Daniel, et al.
Publicado: (2022)